MS

Maneesh Sinha

Active Director Director DIN 09504745
DIN 09504745 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Maneesh Sinha

Data last updated:

Maneesh Sinha is a Director at Urosurge Private Limited (since 2022). The company operates in Healthcare. Urosurge Private Limited reported revenue of ₹7.4 Lakh (FY 2024).

DIN 09504745
Primary Designation Director
Industry Healthcare
First Appointment 14 Feb 2022
Oldest Company Age 4 yrs
Largest company Urosurge Private Limited · ₹7.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Urosurge Private Limited U33302KA2022PTC157908
Director14 Feb 20222022₹7.4 Lakh (FY 2024)Active

Board colleagues of Maneesh Sinha

Directorship timeline

Open interactive timeline →
Urosurge Private Limited
Premium access

Shareholding and investment profile for Maneesh Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maneesh Sinha

Maneesh Sinha currently holds 1 directorship: Urosurge Private Limited (Director, since 14 Feb 2022, revenue ₹7.4 Lakh (FY 2024)).

Maneesh Sinha was first appointed on 14 Feb 2022 as Director at Urosurge Private Limited.

The current boards of Maneesh Sinha's companies include Nandini Raje Sinha (Urosurge Private Limited), Rajkumar Neha (Urosurge Private Limited), Rajkumar Neha (Urosurge Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available